Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to conventional DMARDs: a randomised, double-blind, placebo-controlled phase III trial (RAJ3).

Tanaka Y, Takeuchi T, Tanaka S, Kawakami A, Iwasaki M, Song YW, Chen YH, Wei JC, Lee SH, Rokuda M, Izutsu H, Ushijima S, Kaneko Y, Akazawa R, Shiomi T, Yamada E.

Ann Rheum Dis. 2019 Oct;78(10):1320-1332. doi: 10.1136/annrheumdis-2019-215163. Epub 2019 Jul 26.

2.

Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase III randomised, double-blind, placebo-controlled trial (RAJ4) in Japan.

Takeuchi T, Tanaka Y, Tanaka S, Kawakami A, Iwasaki M, Katayama K, Rokuda M, Izutsu H, Ushijima S, Kaneko Y, Shiomi T, Yamada E, van der Heijde D.

Ann Rheum Dis. 2019 Oct;78(10):1305-1319. doi: 10.1136/annrheumdis-2019-215164. Epub 2019 Jul 26.

3.

Utility of comprehensive genomic sequencing for detecting HER2-positive colorectal cancer.

Shimada Y, Yagi R, Kameyama H, Nagahashi M, Ichikawa H, Tajima Y, Okamura T, Nakano M, Nakano M, Sato Y, Matsuzawa T, Sakata J, Kobayashi T, Nogami H, Maruyama S, Takii Y, Kawasaki T, Homma KI, Izutsu H, Kodama K, Ring JE, Protopopov A, Lyle S, Okuda S, Akazawa K, Wakai T.

Hum Pathol. 2017 Aug;66:1-9. doi: 10.1016/j.humpath.2017.02.004. Epub 2017 Feb 22.

4.

Genomic landscape of colorectal cancer in Japan: clinical implications of comprehensive genomic sequencing for precision medicine.

Nagahashi M, Wakai T, Shimada Y, Ichikawa H, Kameyama H, Kobayashi T, Sakata J, Yagi R, Sato N, Kitagawa Y, Uetake H, Yoshida K, Oki E, Kudo SE, Izutsu H, Kodama K, Nakada M, Tse J, Russell M, Heyer J, Powers W, Sun R, Ring JE, Takabe K, Protopopov A, Ling Y, Okuda S, Lyle S.

Genome Med. 2016 Dec 22;8(1):136. doi: 10.1186/s13073-016-0387-8.

5.

[New Classification for Advanced Colorectal Cancer Using CancerPlex®Genomic Tests].

Kameyama H, Shimada Y, Ichikawa H, Nagahashi M, Sakata J, Kobayashi T, Nogami H, Maruyama S, Takii Y, Okuda S, Ling Y, Izutsu H, Kodama K, Nakada M, Wakai T.

Gan To Kagaku Ryoho. 2016 Nov;43(11):1361-1365. Japanese.

PMID:
27899776
6.

Self-sustained circadian rhythm in cultured human mononuclear cells isolated from peripheral blood.

Ebisawa T, Numazawa K, Shimada H, Izutsu H, Sasaki T, Kato N, Tokunaga K, Mori A, Honma K, Honma S, Shibata S.

Neurosci Res. 2010 Feb;66(2):223-7. doi: 10.1016/j.neures.2009.10.007. Epub 2009 Oct 31.

PMID:
19883700
7.

Trastuzumab-induced CCL20 and interleukin-8 mRNA in human whole blood ex vivo.

Hasegawa S, Kato H, Yamaguchi H, Yohda M, Obara K, Izutsu H, Ogura M, Mitsuhashi M.

Invest New Drugs. 2009 Dec;27(6):579-82. doi: 10.1007/s10637-009-9223-y. Epub 2009 Feb 10.

PMID:
19205624
8.

Ex vivo simulation of the action of antileukemia drugs by measuring apoptosis-related mRNA in blood.

Mitsuhashi M, Endo K, Obara K, Izutsu H, Ishida T, Chikatsu N, Shinagawa A.

Clin Chem. 2008 Apr;54(4):673-81. doi: 10.1373/clinchem.2007.091975. Epub 2008 Feb 21.

9.

Ex vivo induction of mRNA in human whole blood as a new platform of drug and dietary supplement development.

Mitsuhashi M, Ogura M, Endo K, Obara K, Izutsu H, Targan SR, Maemura M, Tachikawa D, Shinagawa A.

Pharm Res. 2008 May;25(5):1116-24. doi: 10.1007/s11095-007-9510-2. Epub 2008 Jan 9.

10.

Hydrogen-bonded complexes of 2-pyridone with centrosymmetric and non-centrosymmetric dicarboxylic acids.

Kashino S, Fukunaga T, Izutsu H, Miyashita S.

Acta Crystallogr C. 2001 May;57(Pt 5):627-31. Epub 2001 May 15.

PMID:
11353274
11.

A Novel Layered Silicate with a Helical Morphology.

Akiyama Y, Mizukami F, Kiyozumi Y, Maeda K, Izutsu H, Sakaguchi K.

Angew Chem Int Ed Engl. 1999 May 17;38(10):1420-1422. doi: 10.1002/(SICI)1521-3773(19990517)38:10<1420::AID-ANIE1420>3.0.CO;2-6.

PMID:
29711586
12.

A case of primary adenosquamous/squamous cell carcinoma of gallbladder directly invaded duodenum.

Saito A, Noguchi Y, Doi C, Mukai K, Fukuzawa K, Yoshikawa T, Amano T, Kondo J, Ito T, Izutsu H.

Hepatogastroenterology. 1999 Jan-Feb;46(25):204-7.

PMID:
10228793
13.

Plaque formation by and plaque cloning of Chlamydia trachomatis biovar trachoma.

Matsumoto A, Izutsu H, Miyashita N, Ohuchi M.

J Clin Microbiol. 1998 Oct;36(10):3013-9.

14.

[Assay of specific anti-Chlamydia pneumoniae antibodies by ELISA method. 2. studies on clinical usefulness and serological diagnostic standards].

Kishimoto T, Kubota Y, Matsushima T, Izutsu H, Matsumoto A, Soejima R, Numazaki K, Chiba S, Yamazaki T, Sasaki N, Kaku M, Shimada J, Iwasaki E, Baba M, Koori Y, Aihara M, Chikumi H, Kosaba S, Nonaka Y, Ouchi K, Yamamoto T, Kashiwagi S, Kawayama T, Ohizumi K, Nagai H, et al.

Kansenshogaku Zasshi. 1996 Aug;70(8):830-9. Japanese.

PMID:
8890551
15.

[Assay of specific anti-Chlamydia pneumoniae antibodies by ELISA method. 1. Evaluation of ELISA kit using outer membrane complex].

Kishimoto T, Kubota Y, Matsushima T, Izutsu H, Matsumoto A, Soejima R, Morikawa T, Kawagoe K.

Kansenshogaku Zasshi. 1996 Aug;70(8):821-9. Japanese.

PMID:
8890550
16.

Efficient production of a small peptide by expression as a multimeric form fused with the dihydrofolate reductase affinity handle.

Takasuga A, Banba K, Yoshino K, Izutsu H, Iwakura M, Ohashi S.

J Biochem. 1992 Nov;112(5):652-7.

17.

Expression and purification of growth hormone-releasing factor with the aid of dihydrofolate reductase handle.

Iwakura M, Obara K, Kokubu T, Ohashi S, Izutsu H.

J Biochem. 1992 Jul;112(1):57-62.

Supplemental Content

Loading ...
Support Center